https://charts.traderzeitung.de/phases/US74112D1019 string(1427) "{"isin":"US74112D1019","name":"Prestige Consumer Healthcare Inc","stock_id_xnas":null,"stock_id_xnys":7872351,"generated_at":"2026-09-24 01:34:00","days":[{"date":"2026-09-21","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":46.79,"close_at":"2026-09-21 21:59:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-22","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":47.76,"close_at":"2026-09-22 21:59:00","complete":true,"perf_pct":2.0731},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-23","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":48,"close_at":"2026-09-23 11:39:00","complete":true,"perf_pct":0.5025},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":45.93,"close_at":"2026-09-23 21:59:00","complete":true,"perf_pct":-4.3125},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":false,"perf_pct":null}]}]}"

Prestige Consumer Healthcare Aktie News & Nachrichten

[WKN: A0DN17 | Symbol: PBH]

Realtimekurs

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige’s key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer’s Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

10J

Alles

Vorbörsliche Indikationen

Regulärer Handel

Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

10.03.2025 um 11 Uhr

Prestige Consumer Healthcare

Prestige Consumer Healthcare überzeugt mit relativer Stärke und bricht auf ein Allzeithoch aus!

Prestige Consumer Healthcare sollte man im Blick behalten. Das Unternehmen ist in der Vermarktung und...

Prestige Consumer Healthcare Nachrichtenticker öffnen

MT Newswires 06.08.2026 15:51 Uhr

Prestige Consumer Healthcare Aktien steigen nach starkem Q1 und angehobener Prognose für das Geschäftsjahr 2027

09:50 AM EDT, 06.08.2026 (MT Newswires) -- Die Aktien von Prestige Consumer Healthcare (PBH) stiegen im frühen Handel am Donnerstag um 5%, nachdem das

MT Newswires 06.08.2026 12:12 Uhr

Earnings Flash (PBH) Prestige Consumer Healthcare Inc. meldet Q1-Umsatz von 265,7 Mio. $, gegenüber einer FactSet-Schätzung von 250,3 Mio. $

MT Newswires 06.08.2026 12:11 Uhr

-- Earnings Flash (PBH) Prestige Consumer Healthcare Inc. meldet im Q1 ein bereinigtes Ergebnis je Aktie von 0,98 USD, verglichen mit der FactSet-Schätzung von 0,88 USD

MT Newswires 30.06.2026 16:16 Uhr

Prestige plant Privatplatzierung von 400 Millionen US-Dollar vorrangiger Anleihen

10:15 AM EDT, 06/30/2026 (MT Newswires) -- Prestige Consumer Healthcare (PBH) teilte am Dienstag mit, dass ihre Tochtergesellschaft, Prestige Brands,

MT Newswires 16.06.2026 13:18 Uhr

Prestige Consumer Healthcare schließt Übernahme von Breathe Right von Foundation Consumer Healthcare ab

07:17 AM EDT, 06/16/2026 (MT Newswires) -- Prestige Consumer Healthcare (PBH) hat seine zuvor angekündigte Übernahme der Breathe Right und anderer bes